skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
Material Type:
Article 		Add to My Research

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern

Science, 2021-08, Vol.373 (6555) [Peer Reviewed Journal]

2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abi7994

Digital Resources/Online E-Resources

Citations Cited by
2
An Opsonic Phagocytosis Assay for Plasmodium falciparum Sporozoites
An Opsonic Phagocytosis Assay for Plasmodium falciparum Sporozoites
Material Type:
Article 		Add to My Research

An Opsonic Phagocytosis Assay for Plasmodium falciparum Sporozoites

Clinical and vaccine immunology, 2017-02, Vol.24 (2) [Peer Reviewed Journal]

Copyright © 2017 American Society for Microbiology. ;Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology ;ISSN: 1556-6811 ;EISSN: 1556-679X ;DOI: 10.1128/CVI.00445-16 ;PMID: 27881488

Full text available

Citations Cited by
3
Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice
Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice
Material Type:
Article 		Add to My Research

Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice

npj vaccines, 2017-10, Vol.2 (1), p.27-27, Article 27 [Peer Reviewed Journal]

The Author(s) 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2017 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-017-0028-2 ;PMID: 29263882

Full text available

Citations Cited by
4
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Material Type:
Article 		Add to My Research

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Cell, 2020-09, Vol.182 (5), p.1295-1310.e20 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 The Author(s) 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.08.012 ;PMID: 32841599

Digital Resources/Online E-Resources

Citations Cited by
5
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
Material Type:
Article 		Add to My Research

SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses

Cell, 2022-03, Vol.185 (5), p.872-880.e3 [Peer Reviewed Journal]

2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022 Elsevier Inc. 2022 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2022.01.011 ;PMID: 35123650

Full text available

Citations Cited by
6
PfCap380 as a marker for Plasmodium falciparum oocyst development in vivo and in vitro
PfCap380 as a marker for Plasmodium falciparum oocyst development in vivo and in vitro
Material Type:
Article 		Add to My Research

PfCap380 as a marker for Plasmodium falciparum oocyst development in vivo and in vitro

Malaria journal, 2018-04, Vol.17 (1), p.135-135, Article 135 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s) 2018 ;ISSN: 1475-2875 ;EISSN: 1475-2875 ;DOI: 10.1186/s12936-018-2277-6 ;PMID: 29609625

Full text available

Citations Cited by
7
Assessing drug efficacy against Plasmodium falciparum liver stages in vivo
Assessing drug efficacy against Plasmodium falciparum liver stages in vivo
Material Type:
Article 		Add to My Research

Assessing drug efficacy against Plasmodium falciparum liver stages in vivo

JCI insight, 2018-01, Vol.3 (1) [Peer Reviewed Journal]

Copyright © 2018, American Society for Clinical Investigation 2018 American Society for Clinical Investigation ;ISSN: 2379-3708 ;EISSN: 2379-3708 ;DOI: 10.1172/jci.insight.92587 ;PMID: 29321371

Full text available

Citations Cited by
8
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Material Type:
Article 		Add to My Research

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

Cell, 2020-11, Vol.183 (5), p.1367-1382.e17 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 The Authors 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.10.043 ;PMID: 33160446

Digital Resources/Online E-Resources

Citations Cited by
9
Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
Material Type:
Article 		Add to My Research

Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses

BioRxiv, 2021-12

2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.12.08.471707

Digital Resources/Online E-Resources

Citations Cited by
10
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Material Type:
Article 		Add to My Research

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

Cell, 2021-10, Vol.184 (21), p.5432-5447.e16 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.09.015 ;PMID: 34619077

Full text available

Citations Cited by
11
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
Material Type:
Article 		Add to My Research

SARS-CoV-2 immune evasion by variant B.1.427/B.1.429

bioRxiv, 2021-04

2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.03.31.437925v1 ;DOI: 10.1101/2021.03.31.437925

Digital Resources/Online E-Resources

Citations Cited by
12
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
Material Type:
Article 		Add to My Research

Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice

Cell Reports, 2022-08, Vol.40 (9), p.111299-111299, Article 111299 [Peer Reviewed Journal]

2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Author(s) 2022 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2022.111299 ;PMID: 35988541

Digital Resources/Online E-Resources

Citations Cited by
13
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Material Type:
Article 		Add to My Research

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

Nature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199

Full text available

Citations Cited by
14
Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
Material Type:
Article 		Add to My Research

Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding

bioRxiv, 2020-06

2020. This article is published under http://creativecommons.org/licenses/by/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2020.06.17.157982

Digital Resources/Online E-Resources

Citations Cited by
15
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Material Type:
Article 		Add to My Research

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

bioRxiv, 2021-03

2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.03.15.435528

Digital Resources/Online E-Resources

Citations Cited by
16
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates
Material Type:
Article 		Add to My Research

Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates

bioRxiv, 2021-02

2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.02.10.430696v1 ;DOI: 10.1101/2021.02.10.430696

Digital Resources/Online E-Resources

Citations Cited by
17
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
Material Type:
Article 		Add to My Research

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2

bioRxiv, 2020-08

2020. This article is published under http://creativecommons.org/licenses/by-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2020.08.11.247395

Digital Resources/Online E-Resources

Citations Cited by
18
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
Material Type:
Article 		Add to My Research

Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice

bioRxiv, 2022-02

2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2022.02.07.479468

Digital Resources/Online E-Resources

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (11)

Refine My Results

Creation Date 

From To
Refine
  1. Before 2017  (1)
  2. 2017 To 2017  (2)
  3. 2018 To 2019  (2)
  4. 2020 To 2021  (11)
  5. After 2021  (3)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait